William Blair Starts Genmab A/S (GMAB) at Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Genmab A/S (GEN:DC) (GMAB) PT Raised to DKK3,450 at JPMorgan
November 14, 2022 2:46 AM ESTJPMorgan analyst James Gordon raised the price target on Genmab A/S (GEN:DC) (NASDAQ: GMAB) to DKK3,450.00 (from DKK2,900.00) while maintaining a Overweight rating.... More
Deutsche Bank Downgrades Genmab A/S (GEN:DC) (GMAB) to Hold
November 14, 2022 2:27 AM ESTDeutsche Bank analyst Emmanuel Papadakis downgraded Genmab A/S (GEN:DC) (NASDAQ: GMAB) from Buy to Hold with a price target of DKK3,100.00.
... MoreDeutsche Bank Downgrades Genmab A/S (GEN:DC) (GMAB) to Hold
November 11, 2022 2:06 PM ESTDeutsche Bank analyst Emmanuel Papadakis downgraded Genmab A/S (GEN:DC) (NASDAQ: GMAB) from Buy to Hold with a price target of DKK3,100.00.
... MoreGenmab A/S (GMAB) PT Raised to $37 at BMO Capital
November 11, 2022 7:22 AM ESTBMO Capital analyst Etzer Darout raised the price target on Genmab A/S (NASDAQ: GMAB) to $37.00 (from $36.00) while maintaining a Market Perform rating.... More
Genmab A/S (GEN:DC) (GMAB) PT Raised to DKK3,150 at Bernstein
November 10, 2022 10:25 AM ESTBernstein analyst Wimal Kapadia raised the price target on Genmab A/S (GEN:DC) (NASDAQ: GMAB) to DKK3,150.00 (from DKK3,000.00) while maintaining a Outperform rating.... More
Credit Suisse Reiterates Neutral Rating on Genmab A/S (GEN:DC) (GMAB)
November 10, 2022 3:03 AM ESTCredit Suisse analyst Dominic Lunn reiterated a Neutral rating and DKK2,800.00 price target on Genmab A/S (GEN:DC) (NASDAQ: GMAB).
... MoreGenmab A/S (GEN:DC) (GMAB) PT Raised to DKK3,300 at Barclays
November 10, 2022 2:55 AM ESTBarclays analyst Emily Field raised the price target on Genmab A/S (GEN:DC) (NASDAQ: GMAB) to DKK3,300.00 (from DKK3,000.00) while maintaining a Overweight rating.... More
